Welcome to our dedicated page for iRhythm Holdings SEC filings (Ticker: IRTC), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
iRhythm Holdings, Inc. filings document the public-company reporting of a digital health care business centered on ambulatory cardiac monitoring. Recent Form 8-K disclosures report operating results, financial condition, guidance-related exhibits, Regulation FD materials, material agreements, executive compensation policy changes, board appointments, and changes in the independent registered public accounting firm.
Proxy materials cover director elections, board and committee structure, executive compensation, equity awards, and stockholder voting matters. The filing record also documents the completed holding-company reorganization under which iRhythm Holdings became successor registrant to iRhythm Technologies, including common-stock continuity and predecessor registration-termination records.
iRhythm Holdings, Inc. executive vice president of strategic business operations Mervin Smith reported selling 1,352 shares of common stock on March 2, 2026 in open‑market transactions at prices around $128.44 per share. The filing states the shares were sold to cover tax withholding obligations from vesting restricted stock units, and Smith held 25,612 shares afterward.
iRhythm Holdings, Inc. executive Chad Patterson, the Chief Commercial & Product Officer, reported open-market sales totaling 4,444 shares of common stock on March 2, 2026, at prices around $128.44 per share.
According to the footnote, these shares were sold to cover tax withholding and remittance obligations tied to vesting Restricted Stock Units, and Patterson continues to hold 58,164 shares directly.
iRhythm Holdings, Inc. executive Patrick Michael Murphy, the company’s CBO and CLO, reported selling 4,357 shares of common stock on March 2, 2026. The shares were sold in several open-market transactions at prices around $128.44 per share to satisfy tax withholding and remittance obligations tied to the vesting of Restricted Stock Units. After these transactions, he continued to hold 63,203 shares of iRhythm common stock.
iRhythm Holdings, Inc. Chief Accounting Officer Marc Wade Rosenbaum reported two small sales of common stock related to equity compensation. On March 2, 2026, he sold 399 shares at $128.447 per share and 417 shares at $128.452 per share. A footnote states these sales were made to cover tax withholding and remittance obligations tied to vesting Restricted Stock Units, rather than discretionary selling. After these transactions, he directly held 16,706 shares of iRhythm common stock.
iRhythm Holdings, Inc. Chief Financial Officer Daniel G. Wilson reported open-market sales of company common stock primarily for tax withholding. On March 2, 2026, he sold a total of 3,395 shares of common stock in several open-market transactions at prices around $128.44 per share to cover tax withholding and remittance obligations related to vesting Restricted Stock Units.
After these sales, Wilson directly owned 35,660 shares of iRhythm common stock and indirectly held 100 shares through The Wilson Living Trust dated July 9, 2015, of which he is the trustee.
iRhythm Holdings, Inc. President and CEO Quentin S. Blackford reported selling a total of 13,813 shares of common stock on March 2, 2026 at prices around $128.44 per share. According to the filing, these shares were sold to cover tax withholding obligations tied to vesting restricted stock units. After these transactions, he directly owned 204,155 shares of iRhythm common stock.
Wilson Daniel G. reported acquisition or exercise transactions in this Form 4 filing.
iRhythm Holdings, Inc. Chief Financial Officer Daniel G. Wilson reported an equity award of 8,361 Restricted Stock Units (RSUs), each representing a contingent right to receive one share of common stock. Following this grant, his directly held common stock position is 39,055 shares.
According to the terms, 25% of the RSUs vest on March 1, 2027, with an additional 25% vesting on each one-year anniversary thereafter, so long as he continues as a service provider through each vesting date. The filing also notes an additional 100 shares of common stock held indirectly through The Wilson Living Trust dated July 9, 2015, for which Mr. Wilson serves as Trustee.
Turakhia Minang reported acquisition or exercise transactions in this Form 4 filing.
iRhythm Holdings, Inc. reported that executive Minang Turakhia received an equity award in the form of Restricted Stock Units (RSUs) covering 10,034 shares of common stock at no cash cost on the grant date. Each RSU represents a right to receive one share if vesting conditions are met.
According to the vesting schedule, 25% of these RSUs vest on March 1, 2027, with the remaining RSUs vesting in equal portions on each one-year anniversary thereafter, as long as Turakhia continues as a service provider through each vesting date. Following this grant, Turakhia directly holds 58,933 shares of common stock.
iRhythm Holdings, Inc. reported that President and CEO Quentin S. Blackford acquired 31,842 shares of common stock through a grant of Restricted Stock Units (RSUs). Each RSU represents the right to receive one share of common stock if vesting conditions are met. Following this award, he directly holds 217,968 shares. According to the grant terms, 25% of the RSUs vest on March 1, 2027 and on each one-year anniversary after that date, as long as he continues as a service provider.
Patterson Chad reported acquisition or exercise transactions in this Form 4 filing.
iRhythm Holdings, Inc. reported that Chief Commercial & Product Officer Chad Patterson received an equity award in the form of restricted stock units. He was granted 10,870 RSUs, each representing a contingent right to receive one share of iRhythm common stock at no cash cost.
According to the vesting schedule, 25% of the RSUs vest on March 1, 2027, with additional 25% portions vesting on each one-year anniversary thereafter, as long as he continues as a service provider through each vesting date. Following this grant, his reported direct ownership increased to 62,608 shares of common stock.